Randomized, double-blind, multicenter trial comparing two doses of arzoxifene (LY353381) in hormone-sensitive advanced or metastatic breast cancer patients.
(Q35211301)
scientific article
scientific article
Language:
Current Data About
Randomized, double-blind, multicenter trial comparing two doses of arzoxifene (LY353381) in hormone-sensitive advanced or metastatic breast cancer patients.
other details
description | scientific article |
External Links
(P356) |
10.1093/ANNONC/MDG368
|
(P698) |
12954577
|
(P5875) |
10583005
|
(P8608) |
release_jnvzz6f7lvf5rgvp7ic4dbujbm
|